The Center for the Study of Gene Structure and Function (Gene Center) of Hunter College of the City University of New York is now comprised of a cadre of 19 biomedical researchers with the common goal of increasing the translational/clinical potential of their research projects to help reduce health disparities. The long-term goal of the Gene Center is to enhance infrastruture to support basic and translational/clinical research and so to reduce minority health disparities. Our goals are to: 1) enable investigator^ to become more successful in obtaining extramural support in biomedical/behavioral research, particularly on diseases that disproportionately impact minority populations;2) foster professional development in the biomedical sciences especially in the areas of Cancer, Neuro/Behavior and Disease Prevention.
Our specific aims are: 1) To build translational/clinical capacity in the areas of Cancer and Neuro/Behavior;2) To build on our existing collaboration with the CTSC;3) To continue to develop interactive telehealth e-platforms of disease prevention;4) To increase R-type funding in the areas of Cancer and Neuro/Behavior. We propose to build on the demonstrated accomplishments of our investigators in order to move their projects to translational/clinical status in collaboration with the Weill Cornell Medical College Clinical and Translationnal Sciennce Center and the RCMI Translational Research Netwok. Our Cancer research focuses on prostate and breast cancers and involve, 1) innovation in treatment;and 2) detection and therapeutics. Neuro/Behavior focuses on, 1) addiction and neuroprotection;and 2) diagnosis of stress disorders. A new and novel area developed collaboratively with the CTSC involves Disease Prevention using telehealth eplatforms to serve the underserved. To accomplish our objectives, we propose to fund six pilot projects, hire three new faculty in the areas of Cancer and/or Neuro/Behavior, maintain/strengthen our biomedical research infrastructure, and provide additional targeted professional development acitivities. We are implementing an evaluation program with clearly defined milestones and metrics that will allow us to assess our progress and correct problems that might arise at all stages of the five-year cycle.
Our goal is to enhance our capacity to conduct targeted research on Cancer and Mental Health through collaborations with our clinical partners. Telehealth strategies will facilitate serving underserved populations. Our research addresses diseases that disproportionally afflict minority populations, and success should reduce health disparities.
|Das, Dibash K; Ogunwobi, Olorunseun O (2017) A novel microRNA-1207-3p/FNDC1/FN1/AR regulatory pathway in prostate cancer. RNA Dis 4:|
|Casjens, Sherwood R; Gilcrease, Eddie B; Vujadinovic, Marija et al. (2017) Plasmid diversity and phylogenetic consistency in the Lyme disease agent Borrelia burgdorferi. BMC Genomics 18:165|
|Singh, Sean; Mohamed, Wasima; Aguessy, Annelie et al. (2017) Functional interaction of PkcA and PldB regulate aggregation and development in Dictyostelium discoideum. Cell Signal 34:47-54|
|Luehring-Jones, Peter; Louis, Courtney; Dennis-Tiwary, Tracy A et al. (2017) A Single Session of Attentional Bias Modification Reduces Alcohol Craving and Implicit Measures of Alcohol Bias in Young Adult Drinkers. Alcohol Clin Exp Res 41:2207-2216|
|Kundu, Nandini; Brekman, Angelika; Kim, Jun Yeob et al. (2017) Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway. Oncotarget 8:47916-47930|
|Luine, Victoria; Gomez, Juan; Beck, Kevin et al. (2017) Sex differences in chronic stress effects on cognition in rodents. Pharmacol Biochem Behav 152:13-19|
|Zhao, Zheng; Xie, Lei; Bourne, Philip E (2017) Insights into the binding mode of MEK type-III inhibitors. A step towards discovering and designing allosteric kinase inhibitors across the human kinome. PLoS One 12:e0179936|
|Qiu, Wei-Gang; Polotskaia, Alla; Xiao, Gu et al. (2017) Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer. NPJ Breast Cancer 3:|
|Madapa, Sudharshan; Gadhiya, Satishkumar; Kurtzman, Thomas et al. (2017) Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands. Eur J Med Chem 125:255-268|
|Avila, Jorge A; Alliger, Amber A; Carvajal, Brigett et al. (2017) Estradiol rapidly increases GluA2-mushroom spines and decreases GluA2-filopodia spines in hippocampus CA1. Hippocampus 27:1224-1229|
Showing the most recent 10 out of 150 publications